Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis

BACKGROUND: Targeted therapy has revolutionized the management of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL); however, relapse still occurs because of the presence of quiescent stem cells, termed leukemia propagating cells (LPCs). This study aimed to assess the phenoty...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Menshawy, Nadia, Abd-Aziz, Sherin M., Elkhamisy, Enas M, Ebrahim, Mohammed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021579/
https://www.ncbi.nlm.nih.gov/pubmed/29963520
http://dx.doi.org/10.5045/br.2018.53.2.138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021579/
https://www.ncbi.nlm.nih.gov/pubmed/29963520
http://dx.doi.org/10.5045/br.2018.53.2.138

Ejemplares similares